Conclusion. Ceftobiprole is a novel, broad-spectrum, parenteral cephalosporin undergoing Phase III clinical trials. Its broad spectrum of activity makes it a candidate for monotherapy of cSSSIs ...

In the news release, ADPH said it is working with the Center for Disease Control's Division of Healthcare Quality Promotion ...

Notably contains: Typescript report [probably by Heatley] of the research carried out by Florey, Abraham, Heatley, Page, etc., from Jan 1955 through to Feb 1961, entitled 'Biological Experiments on ...

The Alabama Department of Public Health issued a statement about its current investigation into certain “adverse events” ...

hotmail.com Background Severe bacterial keratitis (BK) typically requires intensive antimicrobial therapy. Empiric therapy is usually with a topical fluoroquinolone or fortified ...

State Key Laboratory of Pollution Control and Resource Reuse, School of Environment, Nanjing University, Nanjing 210023, P. R. China Key Laboratory of Environmental Remediation and Ecological Health ...

The certification covers the company’s manufacturing facility for cephalosporin, carbapenem, and lyophilized injectable ...

Zevtera will enable physicians to treat this important pathogen more effectively, as it is the only approved cephalosporin specifically for MRSA bloodstream infections.” Under the terms of the ...